These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 197414)

  • 1. Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in platelets.
    Best LC; Martin TJ; Russell RG; Preston FE
    Nature; 1977 Jun; 267(5614):850-2. PubMed ID: 197414
    [No Abstract]   [Full Text] [Related]  

  • 2. Binding of 2-azidoadenosine [beta-32P]diphosphate to the receptor on intact human blood platelets which inhibits adenylate cyclase.
    Macfarlane DE; Mills DC; Srivastava PC
    Biochemistry; 1982 Feb; 21(3):544-9. PubMed ID: 6279146
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclic nucleotides and platelet aggregation. Effect of aggregating agents on the activity of cyclic nucleotide-metabolizing enzymes.
    Barber AJ
    Biochim Biophys Acta; 1976 Sep; 444(2):579-95. PubMed ID: 9149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of human platelet adenylate cyclase by prostacyclin (PGX).
    Gorman RR; Bunting S; Miller OV
    Prostaglandins; 1977 Mar; 13(3):377-88. PubMed ID: 191876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High concentrations of exogenous arachidonate inhibit calcium mobilization in platelets by stimulation of adenylate cyclase.
    Kowalska MA; Rao AK; Disa J
    Biochem J; 1988 Jul; 253(1):255-62. PubMed ID: 2458717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of alpha 2-adrenoceptor agonists and of related compounds on aggregation of, and on adenylate cyclase activity in, human platelets.
    Clare KA; Scrutton MC; Thompson NT
    Br J Pharmacol; 1984 Jun; 82(2):467-76. PubMed ID: 6145472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
    Haslam RJ; Davidson MM; Desjardins JV
    Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human platelet adenylate cyclase by collagen fibres. Effect of collagen is additive with that of adrenaline, but interactive with that of thrombin.
    Farndale RW; Winkler AB; Martin BR; Barnes MJ
    Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):25-32. PubMed ID: 1311555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological actions of prostacyclin and its pharmacological use in platelet studies.
    Moncada S; Whittle BJ
    Adv Exp Med Biol; 1985; 192():337-58. PubMed ID: 3010671
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of protein kinase C activation on human platelet cyclic AMP metabolism.
    Bushfield M; Hopple SL; Gibson IF; Murdoch FA; MacIntyre DE
    FEBS Lett; 1987 Oct; 222(2):299-304. PubMed ID: 2820806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of human platelet adenylate cyclase by prostaglandin D2.
    Mills DC; Macfarlane DE
    Thromb Res; 1974 Sep; 5(3):401-12. PubMed ID: 4373870
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanism of action of vitamin E on platelet function.
    Steiner M; Mower R
    Ann N Y Acad Sci; 1982; 393():289-99. PubMed ID: 6293365
    [No Abstract]   [Full Text] [Related]  

  • 13. A selective thromboxane synthetase inhibitor blocks the cAMP lowering activity of PGH2.
    Gorman RR; Fitzpatrick FA; Miller OV
    Biochem Biophys Res Commun; 1977 Nov; 79(1):305-13. PubMed ID: 200243
    [No Abstract]   [Full Text] [Related]  

  • 14. Calcium-dependent proteolytic stimulation of adenylate cyclase in platelets from spontaneously hypertensive rats.
    Tremblay J; Hamet P
    Metabolism; 1984 Aug; 33(8):689-95. PubMed ID: 6087083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of suramin on increases in cytosolic calcium and on inhibition of adenylate cyclase induced by adenosine 5'-diphosphate in human platelets.
    Hall DA; Hourani SM
    Biochem Pharmacol; 1994 Mar; 47(6):1013-8. PubMed ID: 8147900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic AMP metabolism in cholesterol-rich platelets.
    Sinha AK; Shattil SJ; Colman RW
    J Biol Chem; 1977 May; 252(10):3310-4. PubMed ID: 193833
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of cyclic AMP in platelet function.
    Cole B; Robison GA; Hartmann RC
    Ann N Y Acad Sci; 1971 Dec; 185():477-87. PubMed ID: 4330513
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel 7-oxabicyclo[2.2.1]heptane prostacyclin agonists.
    Haslanger MF; Sprague PW; Snitman D; Vu T; Harris DN; Greenberg R; Powell J
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():293-7. PubMed ID: 6221540
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclic 3',5'-adenosine monophosphate in human blood platelets. 3. The role of cyclic AMP in platelet aggregation.
    Salzman EW; Rubino EB; Sims RV
    Ser Haematol; 1970; 3(4):100-13. PubMed ID: 4329913
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibitory effects of S-(1,2-dicarboxyethyl)glutathione on collagen-induced platelet aggregation; enhancements of cyclic AMP level and adenylate cyclase activity in platelets by S-(1,2-dicarboxyethyl)glutathione.
    Tsuboi S; Fujiwara E; Ogata K; Sakaue A; Nakayama T; Ohmori S
    Biol Pharm Bull; 1993 Nov; 16(11):1083-6. PubMed ID: 8312859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.